483
Dharma Research, Inc.FDA 483 - Dharma Research, Inc. - March 13, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Dharma Research, Inc., a manufacturer in Miami, FL, identified one observation. The firm was cited for inadequately documenting its risk management processes. Specifically, potential risks associated with Jade etchant gels, such as vomiting and diarrhea, were not properly identified in the Failure Mode and Effects Analysis Worksheet.
Open in Dashboard
ID · 556a67cb-8fb7-4255-b4b3-cb762b88d7d8